|
Volumn 25, Issue 4, 2007, Pages 461-462
|
Radiation therapy for ductal carcinoma in situ: Is it really worth it? [4]
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BREAST CANCER;
CANCER INVASION;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CARCINOMA IN SITU;
CLINICAL TRIAL;
HIGH RISK POPULATION;
HUMAN;
LETTER;
METASTASIS;
PRIORITY JOURNAL;
ADJUVANT THERAPY;
BREAST TUMOR;
CAUSE OF DEATH;
CONTROLLED CLINICAL TRIAL;
FEMALE;
NOTE;
PAGET NIPPLE DISEASE;
PATHOLOGY;
PROGNOSIS;
RADIATION INJURY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
TUMOR RECURRENCE;
BREAST NEOPLASMS;
CARCINOMA, INTRADUCTAL, NONINFILTRATING;
CAUSE OF DEATH;
FEMALE;
HUMANS;
NEOPLASM INVASIVENESS;
NEOPLASM RECURRENCE, LOCAL;
PROGNOSIS;
RADIATION INJURIES;
RADIOTHERAPY, ADJUVANT;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
|
EID: 33846989337
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2006.09.1645 Document Type: Letter |
Times cited : (6)
|
References (4)
|